Leadership and Mentorship in the Gx and Biosimilars Space
The Gx and Biosimilars industry plays a critical role in global healthcare by ensuring access to affordable, high-quality medicines.
Celebrating Success: Griffin Bay Advisors Delivers Strategic Impact for Biotech Client
Last December, Griffin Bay Advisors celebrated a key milestone, successfully completing another impactful client engagement.
Setting your Operating Plan
Griffin Bay Advisors has a proven track record of creating successful operating plans in the U.S. and internationally.
Copay Support Challenges: Maximizers and Accumulators
Every year, pharma companies spend billions of dollars on copay support programs to ensure patients can access critical therapies despite high insurance cost-sharing (co-pays and deductibles).
Target, Message, & Align: The Essential Oxygen for Pharma Launch Success
Pharma launches aren’t just critical milestones, they’re oxygen fueling industry growth.
What’s in a Name?
This year, I have started a new page in my life with Griffin Bay Advisors, but Griffin Bay the place will forever be tied to my family and my story.